Completed OBSERVATIONAL NCT00537628

Biomarkers in Acute Heart Failure (BACH)

Biomarkers in Acute Heart Failure: An International, Multi-Center Trial Evaluating the Prognostic and Diagnostic Utility of Biomarkers in Patients With Heart Failure Presenting With Shortness of Breath

Sponsor: Brahms AG

Conditions Heart Failure Shortness of Breath

Updated 10 times since 2017 Last updated: Jul 30, 2008 Started: Mar 31, 2007 Primary completion: May 31, 2008 Completion: Jun 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Heart Failure and Shortness of Breath, this trial is completed. The trial is conducted by Brahms AG and has accumulated 10 data snapshots since 2007. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 5 earlier versions

Jun 2018 — Nov 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Aug 2017 [monthly]

Completed NA

First recorded

Mar 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Brahms AG

Data source: Brahms AG

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Athens, Greece , Baltimore, United States , Basel, Switzerland , Berlin, Germany , Christchurch, New Zealand , Cleveland, United States , Detroit, United States , Leicester, United Kingdom , Minneapolis, United States , Richmond, United States and 4 more locations